Grand Rounds by OncoDaily: AI in Oncology Edition

GeparNuevo Long-Term Analysis: Durvalumab Improves Survival in Early Triple-Negative Breast Cancer

Norbert Kraut: Excited to Share AACR Lung Cancer Task Force Findings

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

Ruiling Yuan: Another Successful Annual Rural Oncology Conference

Oncology News, Insights, Stories by OncoDaily

AACR 2026
Oncolibrary

AACR Annual Meeting 2026: NETs Drive Tumor Necrosis and Metastasis in Colorectal Cancer

Myelo 2026
OncoDaily

Myelo 2026: Virtual Global Congress on Multiple Myeloma

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition
OncoDaily

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Agenus and BAP Pharma Announce Global Partnership to Expand Authorized Access to BOT+BAL

AACR 2026 Recaps Day 3

Ruling Yuan Has Been Named the Advocate of The Year - ASCO

Margaret Foti and AACR Delegates Thank Congress for Protecting NIH/NCI Funding

Advancing Equitable HPV Prevention in Kenya: A Critical Roundtable at Africa Health Business Symposium 2026

Eli Lilly Acquires Kelonia Therapeutics for Up to $7B, Making Bold Entry Into In Vivo CAR-T Cell Therapy

AACR 2026 Recaps Day 2

Voices
Carolyn Taylor

Carolyn Taylor: Having Cancer Lead Me Continue Forward, with Purpose, Commitment, and Love

Ariella Hanker:How Can We Make Mutant Selective PI3Kalpha Inhibitors Work Even Better?

Wafik S. El-Deiry: Glad to Personally Thank Dr. Tony Letai for His Leadership of the NCI at AACR26

Cosimo Commisso: Great to Celebrate Anirban Maitra First AACR Reception as Cancer Center Director

Wade Swenson: Grateful to Be Named Advocacy Champion by ASCO

Ruiling Yuan: Honored to Be Named ASCO 2025 Advocate of the Year

Issue #114 Is Live - Exploring What Progress in Oncology Really Means - CancerWorld

FDA Approvals
Tecartus

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

NCCN 2026 Policy Summit: Innovations in Cancer Care Through the Ages

The National Comprehensive Cancer Network

25 Jun
NCCN

NCCN 2026 Policy Summit: Health Literacy in the Cancer Care Digital Age

The National Comprehensive Cancer Network

07 May
NCCN

NCCN Webinar Series - Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia

The National Comprehensive Cancer Network

06 May
Chronic Lymphocytic Leukemia

NCCN Webinar Series - Precision in Practice: PARPi Combinations and Toxicity Management in Metastatic Prostate Cancer

The National Comprehensive Cancer Network

23 Apr
Prostate Cancer

NCCN Webinar Series - Optimizing Patient Outcomes: The Role of Blinatumomab in Frontline Pediatric ALL

NCCN

22 Apr
Blinatumomab

Immune-oncology
innovaTV Trial Update: Tisotumab Vedotin in Cervical Cancer

innovaTV Trial Update: Tisotumab Vedotin in Cervical Cancer

Spatial Omics for Characterizing the Dynamic Tumor Microenvironment

Beyond the Guideline: What Uveal Melanoma Experts Say Still Needs Attention

10 Must-Read Posts in Immuno-Oncology This Week

10 Clinical Trials on Immunotherapy in Triple Negative Breast Cancer

Microsatellite Instability (MSI)-The Biomarker That Changed Oncology Practice

Uveal Melanoma 2026: What the Latest ESMO–EURACAN Guideline Tells Us

Gastrointestinal-Oncology
Promising Phase I Results for BOT/BAL and agenT-797 in PD-1 Refractory Gastroesophageal Cancer

Promising Phase I Results for BOT/BAL and agenT-797 in PD-1 Refractory Gastroesophageal Cancer

10 Must-Read Posts In GI Oncology This Week

Phase II LEAP-005 Results: Lenvatinib plus Pembrolizumab in Pretreated GI Cancers

ESMO 2026 Guideline: Redefining the Management of Metastatic Colorectal Cancer

Immunotherapy in GI Cancers 2026: From Expansion to Precision

Phase 3 RASolute 302 Trial: Daraxonrasib Improves Overall Survival in Metastatic Pancreatic Cancer

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
GeparNuevo

GeparNuevo Long-Term Analysis: Durvalumab Improves Survival in Early Triple-Negative Breast Cancer

SONIA Trial Challenges Routine First-Line CDK4/6 Use in Advanced Breast Cancer

Single-Cell Spatial Atlas of the Aging Breast: How Normal Tissue Changes May Shape Breast Cancer Risk

4 ADCs That Rewrote Breast Cancer Treatment History

PREDIX LumB: Palbociclib Did Not Beat Chemotherapy, But CDKPredX May Rescue the Strategy

DESTINY-Breast09: The Trial Changing the Future of HER2-Positive Breast Cancer

10 Breast Cancer Studies You Cannot Afford to Miss This Week

Lung-Oncology
CheckMate 77T

CheckMate 77T Biomarker Analysis Highlights ctDNA and Genomic Signals of Benefit With Perioperative Nivolumab in Resectable NSCLC

Zoldonrasib Shows Early Strength in Previously Treated KRAS G12D NSCLC

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable NSCLC: What This 2026 Meta-Analysis Really Shows

First-Line Zongertinib in Advanced HER2-Mutant NSCLC: A New Targeted Standard Begins to Take Shape

Can PD-L1 on Blood Immune Cells Predict Who Benefits From Durvalumab in ES-SCLC?

After 2 Years of Pembrolizumab in Advanced NSCLC, What Happens Next?

2026 ASCO Living Guideline for Stage IV NSCLC: The Updates Clinicians Should Not Miss

OncoDaily TV
Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Noetic Medicine: The Science Behind Healing Through Words

Noetic Medicine: The Science Behind Healing Through Words

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy - Episode 1

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy – Episode 1

ACT for Children Initiative: Making a Durable Change

ACT for Children Initiative: Making a Durable Change

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Ensuring equitable access to cancer care worldwide

Ensuring equitable access to cancer care worldwide: Pat Garcia-Gonzalez

How to Publish High-Impact Research in Top Journals

How to Publish High-Impact Research in Top Journals: Gustavo Monnerat

Empowering Oncologists

Empowering Oncologists: How Social Media Can Lead To Professional Collabortions And Advancement?

Dr. Amar Rewari

Challenges in Modern Cancer Care And How to Address Them: Dr. Amar Rewari

Fight Cancer, City of hope

This Could Change How We Fight Cancer Forever: Dr. Charles M. Balch

Ricardo Marques

The Moment People Ask for Help Is the Moment We Can’t Miss: Ricardo Marques

Not To Miss
ASCO Advocacy Summit

The 2026 ASCO Advocacy Summit Highlights

OncoGrants Weekly: 10 Oncology Grants Open Now — Deadlines from May to September 2026

20 Posts Not To Miss From SIOP Africa 2026

What to Expect at ISCO Annual Congress 2026

Highlights from OncoDaily Session at SELAC 2026

10 Breast Cancer Studies You Cannot Afford to Miss This Week

20 Posts Not To Miss From Texas Lung Cancer Conference 2026

OncoGrants
AACR Immuno‑Oncology Research Fellowship

AACR Immuno‑Oncology Research Fellowship

Damon Runyon–Dale F. Frey Award for Breakthrough Scientists

Damon Runyon–Dale F. Frey Award for Breakthrough Scientists

Damon Runyon Fellowship Award

Damon Runyon Fellowship Award

LCRF Leading Edge Research Grant

LCRF Leading Edge Research Grant

American Cancer Society Clinician Scientist Development Grant

American Cancer Society Clinician Scientist Development Grant

American Cancer Society Postdoctoral Fellowship

American Cancer Society Postdoctoral Fellowship

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
AML

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

CancerWorld

Oncologists
LIdia Schapira

Lidia Schapira

Oncologists Location Stanford, USA
Jean-Yves Blay

Jean-Yves Blay

Oncologists Location Lyon, France
Maria T. Bourlon, MD, MSc, FASCO

María Teresa Bourlon

Oncologists Location Mexico City, Mexico
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany
Nagashree Seetharamu

Nagashree Seetharamu

Oncologists Location Long Island, USA
Sarfraz Ahmad

Sarfraz Ahmad

Oncologists Location Orlando, USA
Garik Sagoyan

Garik Sagoyan

Oncologists Location , USA
Luciano Mutti

Luciano Mutti

Oncologists Location L’Aquila, Italy

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
ROSELLA Trial

The ROSELLA trial: Relacorilant + Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer

Bi-Specific T cell

Bi-Specific T Cell Engagers in Cancer Therapy: Mechanisms, Advances, and Clinical Impact

KRAS G12V

KRAS G12V–Mutated NSCLC: Smoking-Driven Biology and Immunotherapy Sensitivity

KEYNOTE-158

KEYNOTE-158 Trial: Pembrolizumab Monotherapy in MSI-H/dMMR Recurrent Gliomas:

PRINCE Trial

PRINCE Trial: Lu-PSMA-617 Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

NCCN 2026

NCCN Annual Conference 2026: The Evolving Treatment Landscape for Gastric, Esophageal, and EGJ Cancers

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts